Amatuximab (development code MORAb-009) is a chimeric monoclonal antibody designed for the treatment of cancer. It was developed by Morphotek, Inc. Amatuximab...
10 KB (954 words) - 00:22, 8 January 2024
mab mouse Carcinoembryonic antigen (CEA) colorectal cancer (diagnosis) Amatuximab mab chimeric mesothelin cancer Amivantamab Rybrevant BsAb human Epidermal...
136 KB (4,020 words) - 07:14, 15 August 2024
(INN) Amaphen Amaryl (Sanofi-Aventis), also known as glimepiride Amatine amatuximab (USAN) ambamustine (INN) ambasilide (INN) ambazone (INN) ambenonium chloride...
10 KB (488 words) - 05:43, 26 April 2024
paptox Nofetumomab merpentan Pintumomab Tenatumomab Tositumomab Chimeric Amatuximab§ Bavituximab§ Brentuximab vedotin Carotuximab† Cetuximab Derlotuximab...
4 KB (241 words) - 13:42, 14 July 2024
paptox Nofetumomab merpentan Pintumomab Tenatumomab Tositumomab Chimeric Amatuximab§ Bavituximab§ Brentuximab vedotin Carotuximab† Cetuximab Derlotuximab...
5 KB (368 words) - 15:29, 21 August 2024
paptox Nofetumomab merpentan Pintumomab Tenatumomab Tositumomab Chimeric Amatuximab§ Bavituximab§ Brentuximab vedotin Carotuximab† Cetuximab Derlotuximab...
3 KB (129 words) - 01:04, 19 July 2023